Gene-silencing firm Laverock expands team by 50 per cent and hires new FD

Laverock Therapeutics, which is growing fast from its base at Stevenage Bioscience Catalyst, has unveiled Ali Elsley as Finance Director and revealed significant expansion of its team.

Related Keywords

United Kingdom ,Cambridge ,Cambridgeshire ,Eli Lilly ,David Venables ,Group Financial ,University Of Cambridge ,Institute Of Chartered Accountants ,Acacia Pharma Group ,United Kingdom Innovation Science Seed Fund ,Group Financial Controller ,Company Secretary ,Chartered Accountants ,Stevenage Bioscience Catalyst ,Calculus Capital ,Mercia Ventures ,Maven Capital Partners ,United Kingdom Innovation ,Science Seed Fund ,